Flatiron Health

Flatiron Health is a healthtech company dedicated to reimagining the infrastructure of cancer care. Founded in 2012 and now an independent affiliate of the Roche Group, Flatiron operates on a mission to improve and extend lives by learning from the experience of every person with cancer. The company partners with hundreds of cancer centers, more than 20 top global developers of oncology therapeutics, and researchers and regulators around the world to accelerate research and continuously improve the quality of care.

As the pioneer in real-world evidence for oncology, Flatiron provides technology and services that support patient care and make every patient's story count. The company's vision is to build a world where technology and science close the gap between care and research. Flatiron has expanded its global footprint through international subsidiaries in Japan, Germany, and the United Kingdom, partnering with hospitals and health networks in collaborations tailored to each market's legal, regulatory, and compliance requirements.

Core Solutions and Focus Areas

• Accelerating drug development and access: Flatiron works with leading oncology therapeutic developers to generate real-world evidence that informs and speeds up the drug development process, helping bring new treatments to patients more efficiently.
• Powering smarter care: Through its technology platforms, Flatiron supports clinicians at the point of care, enabling data-driven decision-making and improved patient outcomes across cancer centers.
• OncoEMR® platform: Flatiron's point-of-care electronic medical record solution for oncology practices, which supports integrations with partners such as Abbott to expand access to precision oncology tools directly within clinical workflows.
• Real-world evidence (RWE): Flatiron generates and applies real-world evidence to improve patient outcomes, inform health policy, and advance oncology research globally, including AI-powered datasets such as its first-of-its-kind global prostate cancer dataset.

Key Capabilities and Technology

• Real-world evidence generation and analysis purpose-built for oncology research and regulatory use
• AI-powered data products, including global cancer datasets designed to answer critical oncology research questions
• Point-of-care technology solutions that integrate with oncology workflows and third-party precision oncology tools
• Technology and services infrastructure connecting cancer centers, biopharma researchers, and regulatory bodies
• Support for clinical research through participation in major oncology conferences, including the American Society of Genitourinary Cancers Symposium

Partnerships, Compliance, and Global Reach

• Partners with hundreds of cancer centers across the United States and internationally
• Collaborates with more than 20 top global oncology therapeutic developers
• Works with researchers and regulators worldwide to support evidence-based policy and drug approval processes
• Operates as an independent affiliate of the Roche Group, with international subsidiaries in Germany, Japan, and the United Kingdom
• Each international subsidiary operates in compliance with local legal, regulatory, and compliance requirements specific to its market
• Integration partnerships with companies such as Abbott to expand precision oncology capabilities at the point of care

Company Culture and Leadership

• Led by a multidisciplinary executive team including a Chief Executive Officer, Chief Technology Officer, Chief Product Officer, Chief Operating Officer, and dedicated leaders in research sciences, compliance, and point-of-care solutions
• Committed to inclusion and belonging, striving to elevate diverse voices and cultivate an environment where varied perspectives drive innovation in cancer care
• Guided by core values centered on solving problems that matter, prioritizing work that advances the mission, and focusing on meaningful impact for customers and patients
• Actively recruiting across technology, science, and operations roles to build the next generation of changemakers in oncology

Flatiron Health continues to advance its mission of transforming global oncology research and care, using real-world evidence and innovative technology to improve outcomes for every person with cancer — from the clinic to the research lab to the regulatory environment.